Aurobindo Pharma has reported results for the first quarter ended June 30, 2020.
The company has reported over 2-fold jump in its net profit at Rs 714.68 crore for the quarter under review as compared to Rs 330.50 crore for the same quarter in the previous year. Total income of the company increased by 14.03% at Rs 3,545.28 crore for Q1FY21 as compared Rs 3,108.97 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 22.77% in its net profit attributed to owner at Rs 780.58 crore for the quarter under review as compared to Rs 635.83 crore for the same quarter in the previous year. Total income of the company increased by 10.62% at Rs 6,040.37 crore for Q1FY21 as compared Rs 5,460.38 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |